Burstable Health Team
Health In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
3348 articles
Articles
NWB Finland Oy to Showcase AINA Natural Water's Bag-in-Box Packaging at ECRM 2026
NWB Finland Oy will present its AINA Natural Water in 5-liter and 10-liter bag-in-box formats at the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, offering retailers a premium water option with a clear sustainability story.
September 11, 2026Read the full article
Rising Uninsured Rates Threaten Health Coverage for All Americans
As health insurance premiums climb and recent legislative changes take effect, a growing number of Americans are becoming uninsured or underinsured, with broad implications for the entire healthcare system.
September 11, 2026Read the full article
TNT Targets U.S. Retail Expansion at ECRM Sports Nutrition Session
German sports nutrition brand TNT will attend the ECRM Vitamin, Weight Management & Sports Nutrition Session to build retail relationships and accelerate its U.S. expansion.
September 11, 2026Read the full article
Dental Design Studios Expands Full Arch Implants and Emergency Care to Nine Phoenix Offices
Dental Design Studios has expanded its cosmetic, implant, and emergency dental services across nine Phoenix-area locations, improving access to full arch implants, smile makeovers, and same-day urgent care.
September 10, 2026Read the full article
Earth Science Tech's Integrated Healthcare Platform Drives 7.9% Revenue Growth and Debt Reduction
Earth Science Tech Inc. reported fiscal 2026 revenue of $35.7 million, up 7.9% year-over-year, while eliminating long-term debt and strengthening its balance sheet, positioning the company for continued growth without dilutive financing.
September 10, 2026Read the full article
SS Innovations Launches Sri Lanka's First Robotic Cardiac Surgery Program with SSi Mantra 3.0
SS Innovations International has launched Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, marking a significant step in expanding robotic-assisted cardiac care and highlighting the company's growing global footprint and financial performance.
September 10, 2026Read the full article
Optimi Health Plans Phase 2 Psilocybin Trial for Major Depressive Disorder
Optimi Health Corp. announced plans for a multisite Phase 2 clinical trial of psilocybin-assisted therapy for major depressive disorder, set to begin in the first half of 2027.
September 10, 2026Read the full article
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, is advancing to a Phase 2 trial for multiple sclerosis after FDA clearance of its IND application, with potential to address demyelination directly without immune suppression.
September 10, 2026Read the full article
SS Innovations Reports 79% Growth in SSi Mantra Procedures Amid Global Expansion
SS Innovations International announced a 79% increase in SSi Mantra surgical procedures and a 42% expansion of its installed base, signaling growing global adoption of affordable robotic surgery.
September 10, 2026Read the full article
Helus Pharma CEO to Present at Morgan Stanley Global Healthcare Conference
Helus Pharma CEO Michael Halstead will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference, highlighting the company's progress in developing novel treatments for depression and anxiety.
September 10, 2026Read the full article
Onco-Innovations CMO Highlights ONC010's Dual Selectivity in BioMedWire Podcast
Onco-Innovations' CMO discusses the company's lead drug candidate ONC010, which targets the DNA repair enzyme PNKP with two selectivity mechanisms, and its planned first-in-human clinical program.
September 10, 2026Read the full article
Visory Health Named to Fast Company's 2026 Best Workplaces for Innovators List
Visory Health's inclusion on Fast Company's 2026 Best Workplaces for Innovators list highlights its innovative workplace culture that drives its mission to make prescriptions affordable for millions of Americans.
September 9, 2026Read the full article
New Stroke Rehabilitation Guideline Emphasizes Early, Personalized, and Lifelong Recovery
The American Stroke Association's 2026 Guideline for Adult Stroke Rehabilitation and Recovery highlights the importance of starting rehab within 48 hours and tailoring care to individual needs, offering hope for continued progress long after a stroke.
September 9, 2026Read the full article
Earth Science Tech Builds Self-Sustaining Healthcare Conglomerate Through Vertical Integration
Earth Science Tech Inc. (ETST) leverages vertical integration and dual-segment targeting to create a self-sustaining healthcare business, positioning itself for long-term growth.
September 9, 2026Read the full article
Kairos Pharma CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference
Kairos Pharma's CEO will present at a major investment conference, highlighting its lead candidate ENV-105 designed to overcome cancer drug resistance.
September 9, 2026Read the full article
Expert Warns of Hidden Crisis in UTI Diagnosis, Highlighting Need for Advanced Testing
An expert flags a hidden crisis in how UTIs are diagnosed, emphasizing the need for more accurate testing to address recurrent infections and their impact on women's lives.
September 9, 2026Read the full article
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting SPC-15 Progress
Silo Pharma's participation in the IPAC-RS 2026 Nasal Innovation Forum underscores its commitment to advancing SPC-15, a nose-to-brain PTSD treatment, with promising stability data.
September 9, 2026Read the full article
Quantum BioPharma's Lucid-MS Clears FDA Phase 2 Milestone, Offering New Hope for Multiple Sclerosis Treatment
Quantum BioPharma's Lucid-MS has received FDA clearance for a Phase 2 trial, marking a significant step toward a first-in-class therapy that may protect and repair myelin in multiple sclerosis patients.
September 9, 2026Read the full article
GeoVax Welcomes Global Mpox Vaccine Stockpile Launch, Emphasizes GEO-MVA's Role in Diversifying Supply
GeoVax supports the new global mpox vaccine stockpile initiative and highlights its GEO-MVA candidate's readiness to strengthen supply resilience and equitable access.
September 9, 2026Read the full article
ORGANA International Brings Nearly Three Decades of Natural Wellness Experience to ECRM
ORGANA International, a natural wellness company founded in 1997, will attend ECRM to expand its retail presence, leveraging its diverse product portfolio and consumer education approach.
September 9, 2026Read the full article
Translational Longevity Takes Center Stage in August Wellness Index Report
The August Wellness Index Report spotlights translational longevity—the crucial work of moving scientific breakthroughs from lab to patient—ahead of the Translational Longevity Summit in Boston.
September 9, 2026Read the full article